When orthodontic treatment causes perio problems

Having started at Geistlich from the beginning of 2021, Dr Ralf Halbach took the helm as CEO from July. We review his first few months in the company and hazard a guess at what might be expected for Geistlich in the future.

Paul Note has been at the helm of Geistlich Pharma for 16 years. On the occasion of the handover to the new CEO Ralf P. Halbach in mid-2021, we look back with him on the eventful and expansive time at Geistlich.

Instead of extracting or replacing teeth with dental implants, endodontists prefer to prolong the functionality of teeth with traumatized roots. Today advances in technology, procedures and biomaterials allow endodontists to save teeth at an outstanding rate of success.

Over the past 20-years Dr. Pierpaolo Cortellini has shown that a “hopeless tooth” is anything but hopeless. We discussed long-term outcomes, cost-efficiency and reasonable beliefs and expectations.

Geistlich Biomaterials' "The New Daily Practice" website is live!

Dr. Frank Bröseler has been practicing periodontal regenerative therapy for 20 years with great success and has investigated what really matters for patients. We spoke to him about goals, expectations and the best time to re-motivate patients.

The observation of multinucleated giant cells and cutting cones confirms the safety and predictability of periodontal bony regeneration combined with OTM using Geistlich Bio-Oss^®.

A stable and healthy peri-implant soft-tissue is the foundation of implant success and aesthetic excellence.

In a Randomized Controlled Clinical Trial, Dr. McGuire et al. have compared the long-term outcomes of recession coverage with Geistlich Mucograft^® and free gingival graft.¹ Results were equivalent and stable in both test groups, with less morbidity and higher patient satisfaction with Geistlich Mucograft^®. We asked Dr. McGuire to answer some key questions about his findings.

The Sequential Ridge Augmentation Protocol helps achieve bone and soft tissue regeneration in the context of implant placement in a systematic way.¹ We discussed with Dr. Neel Bhatavadekar the importance of soft tissues for implant success and the best way to prepare patients for a staged approach.

Free gingival graft is considered the gold-standard to widen the keratinized tissue in the vestibulum. In 2014, a randomized controlled split-mouth study by McGuire et al. showed that Geistlich Mucograft^® is just as capable of achieving the goal of generating >2 mm of keratinized tissue.¹ Now the authors confirmed the efficacy also in the long run – with follow-up times up to eight years.²

Histology: a closer look at the bone formation.